Porphyria cutanea tarda: Severe clinical complications over a 20 year course;Porphyria cutanea tarda mit schweren klinischen komplikationen: 20jahriger krankheitsverlauf

Hautarzt

Volumn 49, Issue 7, 1998, Pages 571-575

  Krajnc, Ivan ^a,d   Rozman, Blaž ^b   Pahor, Artur ^c  

^a Lehrhospital Maribor

^b Klinik für Rheumatologic

^c NONE

^d Lehrhospital Maribor   (Slovenia)

Author keywords

Calcification and ulceration; Porphyria cutanea tarda; Sclerodermoid changes

Indexed keywords

AMINOTRANSFERASE; CHLOROQUINE; COPROPORPHYRIN; UROPORPHYRIN;

ADULT; ALCOHOL ABUSE; ANAMNESIS; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISEASE COURSE; EYE INFLAMMATION; HUMAN; LIVER CIRRHOSIS; PATIENT COMPLIANCE; PORPHYRIA CUTANEA TARDA; SKIN CALCIFICATION; SKIN ULCER; TREATMENT FAILURE;

ADULT; CALCINOSIS; COPROPORPHYRINS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; SCALP; SKIN; SKIN ULCER; TREATMENT REFUSAL; UROPORPHYRINS;

EID: 0031928682     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050791     Document Type: Article

References (18)

1. Drago F, Battifoglio ML, Gelati G, Rebora A (1995) Very low-dose chloroquine treatment for porphyria cutanea tarda. Acta Derm Veneroll (Stockh) 75:329-330
2. Elder GH (1991) Prophyria cutanea tarda: pathogenesis in relation to therapy. Curr Probl Dermatol 20:91-96
3. Freesemann A, Frank M, Sieg I, Doss MO (1995) Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver. Skin Pharmacol 8:156-161
4. Friedman SJ, Doyle JA, Rochester MB (1985) Sclerodermoid changes of porphyria cutanea tarda: possible relationship to urinary uroporphyrin levels. J Am Acad Dermatol 13:70-74
5. Ghadially FN (1988) Ultrastructural pathology of the cell and matrix, 3rd ed. Butterworths, London, pp 1252-1261
6. Goh CL (1987) Porphyria cutanea tarda simulating scleroderma. Singapore Med J 28:83-88
7. Grossmann ME, Beckers DR, Poh-Fitzpatrick MB, Deleo VA, Harker LC (1979) PQ: clinical features and laboratory findings in 40 patients. Am J Med 67:277-286
8. Herrmann G et al (1996) Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinses in human dermal fibroblasts. J Invest Dermatol 107:398-403
9. Hurley HJ (1992) Porphyrias. In: Mosschella SL, Hurley HJ (eds) Dermatology, 3rd. Saunders, Philadelphia, pp 1667-1681
10. Köstler E, Doss MO (1995) Porphyria cutanea tarda (chronische hepatische Porphyrie). Dtsch Med Wochenschr 120:1405-1410
11. Kemmer C, Reitmann I, Köstler E, Riedel H (1988) Das morphologische Hautschadensbild der Porphyria cutanea tarda. Zentralbl Allg Pathol Anat 134:227-23
12. Lever WF, Schaumberg-Lever G (1990) Histopathology of the skin, 70th ed. Lipin, Philadelphia, pp 462-474
13. Mascaro JM (1991) Porphyria cutanea tarda: clinical manifestations. Cuur Probl Dermatol 20:79-90
14. Montagna W, Kligman AM, Carlisle KS (1992) Atlas of normal human skin. Springer, Berlin Heidelberg New York, pp 106-107
15. Porcel JM, Mirada A, Jordana R, Munoz A (1991) Systemic sclerosis and porphyria cutanea tarda. Ann Rheum Dis 50:270
16. Poh-Fitzpatrick MB (1993) Is porphyria cutanea tarda a paraneoplastic disorder? Clin Dermatol 11:119-124
17. Sigal M, Nahum HD, Crickx B, Bilet S, Mourier-Massicot CH, Belaich S (1990) Porphyria cutanea tarda and scleroderma - chance association or related disease: a case report. Clin Exp Dermatol 15:285-288
18. Timonen K, Niemi KM, Mustajoki P (1991) Skin morphology in porphyria cutanea tarda does not improve despite clinical remission. Clin Exp Dermatol 16:355-358